GC150 The Child Is Too Thin Nutrition And Growth, Nutritional Deficiency States
Nutritional deficiency states in children presenting with excessive thinness result from inadequate caloric or nutrient intake leading to impaired growth, wasting, and conditions such as marasmus or kwashiorkor.
The Child Is Too Thin: Early Growth, Infant Nutrition and Vitamin D
This GC lecture by Professor Patrick Ip tackles a core paediatric scenario: a child who appears "too thin." It covers how to verify growth faltering, interpret anthropometry and trajectory, organise causes, understand early gastrointestinal adaptation, support infant feeding, and prevent vitamin D deficiency in Hong Kong.
Why this matters for exams: The lecture maps directly onto 4 take-home messages the lecturer explicitly highlights [1]:
- Definition of stunting
- Common causes of failure to thrive
- Benefits of breastfeeding
- Importance of vitamin D
The slides' four take-home pillars are stunting, causes of faltering growth, breastfeeding, and vitamin D. Several numerical claims are lecture-era or population-level associations; the notes below preserve them as source material while separating them from current bedside decisions.
1. Key determinants of growth and growth standards 2. Identify the causes of failure to thrive 3. Understand early nutrition and gastrointestinal adaptation 4. Appreciate the importance of breastfeeding [1]
1. Assessing Whether a Child Is "Too Thin"
Important growth parameters/dimensions: (1) Body proportion — compare with self, (2) Growth record — compare with past, (3) Comparison with other babies [1]
The lecture emphasizes that just looking at a child is insufficient — you need bedside examination to identify features like marked wasting over the buttock [1]. This is high yield because examiners may show a clinical photograph and ask you to identify wasting.
| Comparison | What It Tells You | Example |
|---|---|---|
| With self (body proportion) | Whether weight is proportionate to height and head circumference | Weight ≪ height → wasting; Weight ≈ height both low → stunting |
| With past (growth record) | Trajectory — is the child gaining as expected? | Recheck accurate serial measurements; interpret centile-space crossing against birthweight and clinical context |
| With peers (age- & sex-appropriate norms) | Population reference — z-scores on WHO charts | Weight-for-age < −2 SD = underweight |
High Yield
Early growth – key concept: Growth must be assessed (a) relative to peers (age- and sex-appropriate), (b) relative to other growth parameters (weight/height ± head circumference), and (c) relative to previous growth parameters [1]. This three-pronged assessment framework is a common SAQ stem.
Key determinant of growth depends on stage of life and age of child:
- *Fetal / Infancy → Nutrition
- *Primary school → Hormone(s) [1]
Why this matters from first principles: In the fetus and infant, the most rate-limiting factor for growth is substrate supply (calories, protein, micronutrients). The endocrine axis (particularly GH-IGF1) is present but has a relatively minor role. By school age, the GH–IGF-1 axis becomes the dominant driver, which is why GH deficiency typically presents with growth deceleration after infancy, not at birth.
Child growth is the foundation of health and development — a dynamic and interactive process measured relative to norms [1].
Slide Growth Shorthand (Not Diagnostic Cut-offs)
Milestone Value Birth weight 3.2–3.4 kg Weight doubles By 4 months Weight triples By 10 months ½ adult height By 3 years ¾ adult height By 9 years 85% adult head circumference By 3 years
Interpret the Slide Safely
The 4-month doubling and 10-month tripling figures are rough teaching heuristics, not diagnostic deadlines; birth size, prematurity, feeding and individual trajectory matter. Plot measured weight, length/height and head circumference on the appropriate chart rather than diagnosing faltering growth from a memorised multiplier. [10]
3. Child Growth Indicators & WHO Definitions
Child Growth Indicators: Underweight, Stunting, Wasting, Failure to Thrive [1]
Z-score = statistical measurement of a score's relationship to the mean. Z-score of 0 = same as mean. Can be positive or negative, indicating standard deviations above or below the mean. [1]
| Indicator | Measurement | What It Reflects | Clinical Implication |
|---|---|---|---|
| Underweight | Low weight-for-age < −2 SD | Composite (acute + chronic) | General malnutrition screen |
| Stunting | Low height-for-age < −2 SD | Chronic malnutrition | Key health indicator under 5-year-olds |
| Wasting | Low weight-for-height < −2 SD | Acute malnutrition | Suggests recent nutritional insult |
High Yield
Stunting rate under 5-year-old is a key health indicator — this is explicitly highlighted on the lecture slide [1]. Examiners love asking which growth indicator reflects chronic malnutrition → answer is stunting (height-for-age).
In the slide's cross-sectional EAP-ECDS graph, mean cognitive score rose across height-for-age groups and was lower in the stunted group (P < 0.001). [1]
This is an association, not proof that short stature itself caused the developmental difference. Height-for-age is also a marker for antenatal factors, recurrent infection, diet, poverty and caregiving environment. The clinical lesson is to assess growth and development together and intervene on modifiable risks—not to infer an individual child's cognitive potential from height. [11]
4. Faltering Growth (Historical Term: Failure to Thrive)
Failure to Thrive:
- Failure of expected growth in children younger than 3 years
- Downward crossing of two percentile lines in weight over 6 months [1]
The slide's “two percentile lines over 6 months” is a useful historical exam phrase, but it is not a universal definition. NICE uses centile spaces and varies the threshold by birthweight: a fall of ≥1 space if birthweight was < 9th centile, ≥2 spaces if 9th–91st, ≥3 spaces if > 91st, or current weight < 2nd centile. Confirm measurement technique, plot weight and length/height, review the trajectory, and assess the child rather than labelling from one number. [12]
The lecture organizes causes by the processing of nutrition [1]:
FTT = Problem with getting calories in, breaking them down, using them, keeping them, or needing too many| Category | Examples (from lecture) |
|---|---|
| Inadequate intake — feeding system/caregiver contributors | Ineffective milk transfer, incorrect formula dilution, feeding schedule/environment, food insecurity, caregiver illness or misunderstanding; assess support needs without blame |
| Inadequate intake — child contributors | Cleft palate or other anomaly, dysphagia/neurodisability, cardiopulmonary fatigue, feeding aversion, vomiting or painful feeding |
| Abnormal digestion/absorption (Malabsorption) | Primary: Uncommon (e.g. cystic fibrosis). Secondary: Post-gastroenteritis (common), NEC, short gut syndrome, food allergy/intolerance |
| Inability to utilize (Defective use of calories) | Genetic/syndromal diseases, metabolic disorders (inborn errors of CHO metabolism, aminoacidopathies) |
| Excessive loss | (Implied: chronic diarrhoea, vomiting, renal losses) |
| Increased calorie requirements | Chronic/recurrent infection (UTI, TB), chronic respiratory insufficiency (BPD, CF), congenital/acquired heart disease, malignancy, chronic anaemia, toxins (lead), drug excess (thyroxine), endocrine disorders (hyperthyroidism) |
High Yield
The slide labels post-gastroenteritis malabsorption “common.” Treat this as a context-dependent teaching example, not a universal ranking. Persistent diarrhoea after gastroenteritis may reflect transient mucosal injury/secondary lactose malabsorption, but also consider ongoing infection, coeliac disease after gluten exposure, cow's-milk protein disease, pancreatic disease and non-GI causes according to the presentation.
Exam Trap
Students often forget that increased energy requirements can contribute. In congenital heart disease or chronic lung disease, tachypnoea and cardiorespiratory work may coexist with poor intake and feeding fatigue—categories frequently overlap.
- Verify serial measurements and chart choice; correct age for prematurity when appropriate.
- Take a medical, developmental and psychosocial history plus a detailed 24-hour feeding/eating history.
- Observe a feed or meal with an appropriately trained clinician when milk transfer, swallow safety, technique or interaction is uncertain.
- Examine hydration, fat and muscle stores, oedema, oral cavity, cardiorespiratory system, abdomen, skin/hair and development.
- Use targeted tests only when the history/examination indicates them; NICE specifically highlights urine infection and coeliac testing (once gluten has been introduced), rather than a blanket “FTT panel.” [12]
5. GI Adaptation & Nutrition Uptake in Early Life
This section is uniquely paediatric and the lecture devotes many slides to it. Understanding why infant digestion is different from adults explains many clinical scenarios (reflux, FTT in preterm babies, why early enteral feeding matters).
Coordinated sucking and swallowing → Gastric emptying → Intestinal motility → Secretions (salivary, gastric, pancreatic, hepatobiliary) → Enterocyte function (enzyme synthesis, absorption, mucosal protection) → Metabolism of digestion products → Expulsion of waste [1]
Fetal GI tract is exposed to constant passage of amniotic fluid containing growth factors, hormones, enzymes, and immunoglobulins → these play a role in mucosal differentiation, GI development, swallowing, and intestinal motility [1]
The gut of the newborn must transition from continuous amniotic fluid passage to digesting large quantities of intermittent boluses of milk [1]
| Hormone | Role in Early Infancy |
|---|---|
| Motilin | Increased gut motility |
| Enteroglucagon | Trophic to gut mucosa |
| Enteroglucagon, gastrin, pancreatic polypeptides | Intestinal mucosal and pancreatic growth |
| GIP | Stimulus to glucose-dependent insulin release; the modern name is glucose-dependent insulinotropic polypeptide (historically “gastric inhibitory peptide”) |
GI peptides are found in venous cord blood at birth at levels similar to fasting adults. In fetal distress, gut peptides are elevated → may account for passage of meconium (meconium-stained liquor; MSL) [1]
High Yield
The slide's physiology supports early enteral nutrition, but feeding a preterm or critically ill neonate is a protocolised clinical decision: haemodynamic stability, gestation, human-milk availability and NEC risk determine timing and advancement. “Tiny volumes prime the gut” is a physiological rationale, not a licence to feed every unstable infant.
5.5 Immature Digestion — The Big Tables
| Factor | Early Infancy vs Adult |
|---|---|
| Gastric acid | Lower production |
| Trypsin | Activity reduced |
| Chymotrypsin | Low levels |
| Pancreatic proteases | Low levels |
| Intestinal mucosal peptidases | Adequate |
Clinical takeaway: Despite low gastric acid and pancreatic proteases, brush border peptidases are mature → protein digestion is reasonably functional even in neonates.
| Factor | Early Infancy vs Adult | Compensating Mechanism |
|---|---|---|
| Salivary amylase | Lower levels | Stays active in stomach |
| Pancreatic amylase | Very low levels | Breastmilk amylase |
| Disaccharidases | Adequate levels | Fermentation & absorption in large intestine |
Key point: Low pancreatic amylase is partly compensated by salivary/human-milk amylase and intestinal/colonic processing. It does not justify a blanket claim that an infant “cannot digest starch.” Complementary feeding is based on age, developmental readiness and nutritional need: WHO recommends introduction around 6 months; ESPGHAN advises not before 4 months and not after 6 months. [13][14]
| Factor | Early Infancy vs Adult | Compensating Mechanism |
|---|---|---|
| Pancreatic lipase | Very low levels | Lingual, gastric and breastmilk lipase |
| Bile acids | Low levels | Bile salt-stimulated lipase (in breast milk) |
Clinical relevance: This explains why breastfed infants absorb fat more efficiently than formula-fed infants — breast milk provides its own bile salt-stimulated lipase. Formula-fed preterm infants may have steatorrhoea due to both low pancreatic lipase and low bile acid levels.
Pancreatic function is relatively deficient at birth. Mature levels of pancreatic enzymes are not achieved until late infancy. Pancreatic amylase activity increases after 4–6 months. Lipase levels do not approach adult efficiency until about 6 months. [1]
Upper GI:
Esophageal motility is decreased. LES is primarily above the diaphragm. LES pressure is less for first months. Gastric emptying may be delayed. [1]
Reflux is common in infancy, but the old “weak LES” explanation is incomplete: transient LES relaxations, liquid diet, short oesophagus and frequent feeds contribute. Distinguish physiological regurgitation in a thriving infant from red flags such as bilious/bloody vomiting, forceful vomiting, dysphagia, aspiration, pain, dehydration or faltering growth.
Intestinal:
Intestinal motility is more disorganized. Prolonged transit time in upper intestines may improve absorption. Rapid emptying of ileum and colon may reduce time for water and electrolyte absorption → increased risk of dehydration. [1]
| Event | Timing |
|---|---|
| LES tone increases → less reflux | After 6 months |
| Gastric acid & pepsin reach adult levels | By 2 years |
| Pancreatic amylase increases | By 6 months |
| Lactase activity retained | Until 3–5 years |
| Fat absorption approaches adult efficiency | By 6 months |
| Lipase reaches adult levels | By 2 years |
High Yield
The slide's 3–5-year statement describes the usual timing of genetically programmed lactase decline, not a deadline. Primary congenital lactase deficiency is rare; secondary lactase deficiency can occur at any age with small-bowel mucosal injury.
Limited ability to concentrate urine in first year due to immaturities of nephron and pituitary. Potential renal solute load is determined by nitrogenous end products of protein metabolism, Na, K, P, Cl. [1]
| Feeding | Renal Solute Load (mOsm/L) |
|---|---|
| Human milk | 93 |
| Milk-based formula | 135 |
| Soy protein formula | 165 |
| Evaporated milk formula | 260 |
| Whole cow milk | 308 |
Exam Trap
The table's exact renal-solute values are lecture-era formulation data, so do not assume they apply to every current product. The conclusion remains: whole cow's milk should not be the main drink before 12 months. It has an inappropriate nutrient profile, can increase intestinal blood-loss/iron-deficiency risk, and imposes a higher protein/mineral load; use breast milk or regulated infant formula. Cow's milk can still be used in food preparation after complementary feeding begins. [15]
6. Breastfeeding
Prolactin → milk production; Oxytocin → milk ejection (let-down reflex) via myoepithelial cell contraction. Oxytocin also causes uterine contraction. [1]
The slide diagram shows the neuroendocrine reflex arc [1]. A useful correction is that prolactin from the anterior pituitary drives milk synthesis by alveolar epithelial cells, whereas oxytocin from the posterior pituitary contracts myoepithelial cells for milk ejection:
Infant suckling → Hypothalamus → Pituitary gland
├─ Prolactin → Lacteal / alveolar cells → Milk production
└─ Oxytocin → Myoepithelial cells → Milk ejection (let-down)
→ Uterus → Uterine contractionEnergy: 67 kcal/100 mL
- CHO: lactose, oligosaccharides
- Proteins: lactoferrin (LF), α-lactalbumin, β-casein, lysozyme; cytokines, antibodies
- Fat: LC-PUFA (DHA, AA, EPA)
- Micronutrients & trace metals
- Cells: macrophages, neutrophils, lymphocytes [1]
The slide infographic's “over 400” count is promotional rather than a stable scientific classification. Human milk contains a changing mixture of nutrients, oligosaccharides, enzymes, immune cells and signalling molecules that varies across colostrum/mature milk, within a feed and between parents. When human milk is unavailable, contraindicated or not chosen, regulated infant formula is the appropriate nutritional alternative; families need practical, non-judgemental support for safe preparation.
6.3 Advantages of Breastfeeding
Nutritional value: best composition with high bioavailability Associated with lower risk of some infections and later obesity in observational evidence Allergy prevention is not guaranteed Less contamination, readily available Enzymes, hormones and immune factors [1]
Breast milk offers unique immunologic protection that matches with the sequence of postnatal development of the immune system and helps adaptation of the GI tract from fetal to postnatal life [1]
Three overlapping groups of bioactive agents:
- Direct-acting antimicrobial agents
- Anti-inflammatory agents
- Immunomodulating agents → Biological plausibility for protection against infection and immune modulation; “protection against atopy” is not an absolute clinical promise [1]
| Historical slide claim | Displayed relative increase |
|---|---|
| Diabetes | 40% |
| Obesity | 25% |
| Recurrent ear infection | 60% |
| Hospitalisation for asthma or pneumonia | 250% |
| Death in first year | 27% |
Source: historical percentages displayed on slide 54. [1]
Do not quote these percentages as current, causal effects for an individual family. The slide gives no denominator, comparator, confidence interval or source beside each estimate; breastfeeding studies are strongly affected by socioeconomic, healthcare and behavioural confounding, and effect sizes differ by setting. The defensible message is that breastfeeding is associated with lower infant gastrointestinal/respiratory infection and otitis risk, while longer-term metabolic/allergic outcomes are generally smaller and less certain. [16]
Oxytocin-mediated uterine involution and associations with lower breast/ovarian cancer and type 2 diabetes risk [1]
The slide's “breast cancer 39%” and “type 2 diabetes 14%/year” figures are not usable without the original exposure definition and comparator. Postnatal depression and breastfeeding have a bidirectional relationship; breastfeeding difficulty may worsen distress and depression may impede feeding. Screen and treat the parent rather than presenting lactation as prevention or cure.
Breastfeeding can support close contact, but attachment is not exclusive to breastfeeding, and the slide does not establish that feeding method prevents school withdrawal, behavioural problems or child abuse. The contraceptive effect is reliable only as the lactational amenorrhoea method when all three are true: amenorrhoea, fully/nearly fully breastfeeding, and < 6 months postpartum; otherwise offer standard contraception.
Less medical consultations, less hospitalisations, less medical expense related to infections [1]
The Chinese economic table is a modelled, historical projection, not observed annual cash savings. Its disease assumptions, prices and feeding counterfactuals are not transferable to current Hong Kong practice.
Local data from the Department of Health Family Health Service (2012 birth cohort) show a steep decline in breastfeeding with age [1]:
| Infant Age | Any Breastfeeding (%) | Exclusive Breastfeeding (%) |
|---|---|---|
| < 1 month | 82.9 | — |
| 1 month | 68.6 | 22.1 |
| 2 months | 55.5 | 21.7 |
| 4 months | 44.3 | 19.1 |
| 6 months | 32.7 | 2.3 |
Read the Historical Graph
The 2012 Hong Kong graph falls from 82.9% receiving any breast milk before 1 month to 32.7% at 6 months; exclusive breastfeeding is 22.1% at 1 month and 2.3% at 6 months. These are cohort-era surveillance figures, not current prevalence and not directly comparable with countries using different survey definitions. [1]
The slide lists fatigue, stress, sleep disruption, transmissible infection, medication exposure and infant metabolic disease. Reframe these as reasons to offer skilled feeding, mental-health and practical support—not inherent harms or parental failure. [1]
Exam Trap
True contraindications are rare and depend on jurisdiction. They include classic galactosaemia in the infant, maternal HTLV-1/2, and selected cytotoxic/radioactive exposures; active herpes lesions preclude feeding from the affected breast until safe. HIV advice depends on viral suppression, national policy and the safety of alternatives—WHO supports breastfeeding with effective ART in many settings, while current CDC guidance uses sustained viral suppression and shared decision-making. CMV is mainly a concern for very preterm infants. “Psychiatric drugs” is dangerously broad: many are compatible, and each drug should be checked in LactMed or with pharmacy/paediatrics. [17][18][19]
Exclusive breastfeeding is recommended up to 6 months of age, with continued breastfeeding along with appropriate complementary foods up to 2 years of age or beyond [1]
7. Vitamin D Deficiency — A Critical Nutritional State
Vitamin D supports calcium/phosphate homeostasis and skeletal mineralisation. [1]
Vitamin D deficiency during infancy is associated with:
- Growth retardation
- Skeletal deformities
- Hypocalcaemia and seizures in severe cases [1]
The slide's “over one billion” prevalence and broad immune/brain/psychiatric list depend on contested biochemical thresholds and observational associations. For a healthy child, the established clinical target is prevention of rickets and hypocalcaemia; low 25(OH)D associated with allergy, autoimmunity or psychiatric disease does not prove causation or that supplementation treats those diseases. The 2024 Endocrine Society guideline does not endorse routine 25(OH)D testing in healthy children and could not define a universal blood threshold for disease prevention. [20]
Rickets is one of the most common health problems related to vitamin D deficiency. It affects bone development in children and can cause bone pain, poor growth, and bone deformities. [1]
The image-heavy rickets slide illustrates the pattern to recognise [1]:
- Stunted growth
- Large forehead (frontal bossing)
- Spinal curvature and chest/rib deformity, including rachitic rosary
- Large abdomen
- Wide joints at elbow and wrist
- Widened wrists/ankles and bowed legs
Confirm suspected rickets with dietary/risk history and biochemical/radiographic assessment; not every bowed leg is nutritional rickets.
From first principles: Vitamin D supports intestinal calcium/phosphate absorption and mineralisation. Deficiency causes secondary hyperparathyroidism, renal phosphate wasting and failure of growth-plate/osteoid mineralisation; serum calcium may be maintained until deficiency is severe. This produces rickets in growing children (bowing, rachitic rosary, craniotabes, widened wrists) and osteomalacia after growth-plate closure.
Stunting reflects impaired growth and development from poor nutrition, repeated infection, and inadequate psychosocial stimulation. Vitamin D deficiency was identified as one risk factor for stunting. There is possible interaction with GH and IGF-1. [1]
The pictured paper is an observational association from a specific population. It does not establish vitamin D deficiency as a stand-alone cause of population stunting or prove a GH–IGF-1 treatment mechanism. Stunting is multifactorial; assess dietary calcium/vitamin D when indicated while also addressing total diet, recurrent disease and social/developmental context.
Vitamin D participates in immune signalling, but the slide's arrow “lower vitamin D → greater disease severity” converts correlation into causation. Inflammatory illness, reduced outdoor activity, diet, adiposity and treatment can all lower measured 25(OH)D. Do not use vitamin D to diagnose or treat allergy/autoimmune disease outside indication-specific guidance. [20]
Thresholds used in the local study:
- Sufficiency: > 50 nmol/L
- Insufficiency: 25–50 nmol/L
- Deficiency: < 25 nmol/L (serum total 25(OH)D) [1]
| Finding | Detail |
|---|---|
| Infants/toddlers | Low values cluster visually at roughly 2–10 months, but the scatter also shows wide overlap and outliers |
| Pregnant women | The age scatter shows no obvious age trend; it does not test other predictors |
These were the study's analytical categories, not universal screening targets. Assay, population and clinical indication matter; avoid labelling a healthy child from a single threshold detached from local guidance. [20]
Risk factors: being a girl, low family income, multiparous mother, no vitamin supplementation, sunscreen application, maternal smoking history. A dose-response pattern exists — the more risk factors, the higher the probability of vitamin D insufficiency. [1]
Occurrence of multiple risk factors is the main reason for higher risk of vitamin D insufficiency among breastfed infants [1]
The lecture presents a dose-response table showing odds ratios for vitamin D insufficiency by breastfeeding status and cumulative risk factor count [1]:
| Breastfeeding Status | Partially BF (OR) | Exclusively BF (OR) |
|---|---|---|
| Not breastfed | Ref | Ref |
| BF + 1 risk factor | 1.01 | 2.01 |
| BF + 2 risk factors | 4.25 | 5.90 |
| BF + 3 risk factors | 4.42 | 29.97 |
| BF + 4 risk factors | 13.73 | 40.80 |
The bar chart shows a steep association as risk factors accumulate, especially in exclusively breastfed groups, but the very large odds ratios likely have wide uncertainty and do not prove that breastfeeding caused deficiency. The practical response is supplementation, not discouraging breastfeeding.
High Yield
Hong Kong's current Family Health Service advice is broader: all breastfed infants—exclusive or mixed feeding—should receive vitamin D 400 IU (10 micrograms) daily from birth to 12 months. Exclusively formula-fed infants generally do not need an additional supplement because formula is fortified. Avoid duplicate vitamin-D products and do not exceed the recommended dose unless prescribed. [21]
Clinicians should provide practical supplementation instructions and identify children with additional risks. [1]
Do not prescribe deliberate direct sun exposure to an infant as a substitute for the recommended supplement; Hong Kong guidance advises shade because infants are vulnerable to UV injury. After 12 months, diet and safe outdoor activity usually contribute, with supplementation considered for limited sun exposure, dark skin/covering clothing, obesity, or liver/kidney and other relevant disease. [21]
While the GC lecture focuses on FTT in infancy and vitamin D, the exam may test severe malnutrition (marasmus vs kwashiorkor), drawing from Adrian Lui's notes [2]:
| Feature | Marasmus | Kwashiorkor |
|---|---|---|
| Appearance | Wasted, wizened, apathetic | Generalised oedema on top of severe wasting |
| Mechanism | Severe energy/nutrient deprivation with loss of fat and muscle | Oedematous severe acute malnutrition is multifactorial; the old “pure protein deficiency” explanation is incomplete |
| Skin | Loose, wrinkled | 'Flaky-paint' rash, hyperkeratosis, desquamation |
| Hair | Thin | Sparse, depigmented |
| Abdomen | — | Distended, hepatomegaly (fatty infiltration) |
| Other | — | Angular stomatitis, ↓albumin, ↓K, ↓Mg, ↓glucose |
Severe acute malnutrition in children 6–59 months is identified by nutritional oedema and/or weight-for-height/length <−3 z and/or MUAC < 115 mm; oedema can hide wasting. This requires guideline-based assessment and treatment, not ordinary outpatient “catch-up calories.” [22]
Management of severe malnutrition follows a phased approach [2]:
- Stabilisation: Correct hypoglycaemia, hypothermia, dehydration, electrolyte imbalance, micronutrient deficiency, infection
- Rehabilitation: Catch-up growth, sensory stimulation, emotional support, long-term follow-up
- Refeeding syndrome risk: Hypophosphataemia is the hallmark → monitor PO₄, K, Mg when refeeding [5]
9. Integration with Related Material
The differential of short stature complements the FTT framework:
- Non-pathological ( > 90%): Genetic short stature, constitutional delay
- Pathological proportionate: Chronic illness (weight < height centile), endocrine (weight > height centile)
- Pathological disproportionate: Rickets, skeletal dysplasia
- 2024 MCQ Q92: 5-year-old girl, height < 3rd centile, webbed neck, low-set ears → Turner syndrome (syndromic short stature) [6]
- 2024 MCQ Q93: 7-year-old with CP, weight-for-height < 3%, chronic cough → choking on feeding (aspiration due to swallowing dysfunction → inadequate intake + recurrent aspiration pneumonia) [6]
- 2022 MCQ Q87: Dehydrated toddler with gastroenteritis → fluid management scenario (connects to the lecture's point about rapid ileal/colonic emptying → dehydration risk in infants) [7]
High Yield Summary
- Growth: never diagnose “too thin” by appearance alone. Measure accurately, plot weight/length or height/head circumference, compare proportions and serial trajectory, and examine fat/muscle stores and oedema.
- WHO population indicators: stunting = height-for-age <−2 z; wasting = weight-for-height <−2 z; underweight = weight-for-age <−2 z. They describe different dimensions and do not identify the cause.
- Faltering growth: the slide's “two lines in six months” is not universal. Verify measurements, take medical/developmental/social and feeding histories, and directly observe feeding when indicated.
- Causes overlap: inadequate intake or transfer, impaired digestion/absorption, altered utilisation/loss, and raised requirements may coexist.
- Infant feeding: human milk contains dynamic nutritional and bioactive components; regulated formula is a safe alternative when needed. Interpret historic benefit percentages as associations, not promises or blame.
- Current recommendation: exclusive breastfeeding for about 6 months, then complementary foods with continued breastfeeding to 2 years or beyond when mutually desired and feasible. [13][16]
- Vitamin D in Hong Kong: all exclusively or partly breastfed infants should receive 400 IU (10 micrograms) daily from birth to 12 months; formula-only infants generally do not need extra. [21]
- Image recognition: buttock wasting signals loss of subcutaneous fat; rickets suggests frontal bossing, rachitic rosary, widened wrists/ankles and bowed legs.
Active Recall - Lecture Notes
[1] Lecture slides: GC 150. The child is too thin nutrition and growth, nutritional deficiency states.pdf [2] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 96, 101) [3] Senior notes: Maksim Paediatric Notes.pdf (p. 41) [4] Lecture slides: CFB (OGPAE02-2) Physiology of Lactation, Breast Feeding and Infant Feeding (Part II).pdf [5] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (p. 23 — refeeding syndrome) [6] Past papers: 2024 Fourth Summative MCQ.pdf (Q92, Q93) [7] Past papers: 2022 Fourth Summative MCQ.pdf (Q87) [10] WHO. Child growth standards: questions and answers (2025). https://www.who.int/news-room/questions-and-answers/item/child-growth-standards [11] WHO. Malnutrition in children: stunting, wasting and underweight definitions. https://www.who.int/data/nutrition/nlis/info/malnutrition-in-children [12] NICE NG75. Faltering growth: recognition and management — recommendations. https://www.nice.org.uk/guidance/ng75/chapter/Recommendations [13] WHO. Infant and young child feeding. https://www.who.int/news-room/fact-sheets/detail/infant-and-young-child-feeding [14] ESPGHAN Committee on Nutrition. Complementary Feeding: A Position Paper. J Pediatr Gastroenterol Nutr. 2017. https://doi.org/10.1097/MPG.0000000000001454 [15] CDC. Cow's Milk and Milk Alternatives. https://www.cdc.gov/infant-toddler-nutrition/foods-and-drinks/cows-milk-and-milk-alternatives.html [16] American Academy of Pediatrics. Breastfeeding and the Use of Human Milk: Policy Statement. Pediatrics. 2022. https://doi.org/10.1542/peds.2022-057988 [17] CDC. Contraindications to Breastfeeding (updated 2025). https://www.cdc.gov/breastfeeding-special-circumstances/hcp/contraindications/index.html [18] WHO. Infant feeding for prevention of mother-to-child transmission of HIV. https://www.who.int/tools/elena/interventions/hiv-infant-feeding [19] US National Library of Medicine. Drugs and Lactation Database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK501922/ [20] Endocrine Society. Vitamin D for the Prevention of Disease: Clinical Practice Guideline (2024). https://www.endocrine.org/clinical-practice-guidelines/vitamin-d-for-prevention-of-disease [21] Hong Kong Department of Health, Family Health Service. Vitamin D for Infants and Young Children (revised 2026). https://www.fhs.gov.hk/english/health_info/child/30078.html [22] WHO. Definitions of moderate and severe wasting in children under 5. https://tbksp.who.int/en/node/3168
GC149 Premature Puberty Puberty And Related Disorders
Premature puberty is the onset of secondary sexual characteristics before age 8 in girls or age 9 in boys, resulting from early activation of the hypothalamic-pituitary-gonadal axis (central) or peripheral sex steroid production (peripheral).
GC151 The Malformed Child Hereditary Syndromes And Anomalies
Hereditary syndromes and anomalies in the malformed child encompass genetically determined patterns of congenital structural defects arising from chromosomal abnormalities, single-gene mutations, or multifactorial inheritance that result in recognizable dysmorphic features and developmental malformations.